G
Galmed Pharmaceuticals Ltd D
D
GLMD
1.42000
USD
-0.13
(-8.39%)
مفتوح الان
حجم التداول
600
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
7,754,573
الأخبار المقالات
العنوان: Galmed Pharmaceuticals Ltd
القطاع: Healthcare
الصناعة: Biotechnology
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.